Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cystic fibrosis: the conductance regulator, ceramides, and possible treatments.

Literature DB >> 28831504

Cystic fibrosis: the conductance regulator, ceramides, and possible treatments.

Friedrich C Luft¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28831504 DOI： 10.1007/s00109-017-1577-6

Source DB: PubMed Journal: J Mol Med (Berl) ISSN： 0946-2716 Impact factor: 4.599

× No keyword cloud information.

13 in total

1. Ceramide and sphingosine in pulmonary infections.

Authors: Aaron P Seitz; Heike Grassmé; Michael J Edwards; Yael Pewzner-Jung; Erich Gulbins
Journal: Biol Chem Date: 2015-06 Impact factor: 3.915

2. Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.

Authors: Brahmchetna Bedi; Nicholas M Maurice; Vincent T Ciavatta; K Sabrina Lynn; Zhihong Yuan; Samuel A Molina; Myungsoo Joo; William R Tyor; Joanna B Goldberg; Michael Koval; C Michael Hart; Ruxana T Sadikot
Journal: FASEB J Date: 2017-04-25 Impact factor: 5.191

3. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.

Authors: Dušan Garić; Juan B De Sanctis; Gabriella Wojewodka; Daniel Houle; Shanon Cupri; Asmahan Abu-Arish; John W Hanrahan; Marian Hajduch; Elias Matouk; Danuta Radzioch
Journal: J Mol Med (Berl) Date: 2017-07-10 Impact factor: 4.599

Review 4. Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.

Authors: Joseph L Bobadilla; Milan Macek; Jason P Fine; Philip M Farrell
Journal: Hum Mutat Date: 2002-06 Impact factor: 4.878

Review 5. Sphingolipids in lung growth and repair.

Authors: Jeroen Tibboel; Irwin Reiss; Johan C de Jongste; Martin Post
Journal: Chest Date: 2014-01 Impact factor: 9.410

Review 6. PPARγ as a therapeutic target in cystic fibrosis.

Authors: Johanna F Dekkers; Cornelis K van der Ent; Eric Kalkhoven; Jeffrey M Beekman
Journal: Trends Mol Med Date: 2012-04-09 Impact factor: 11.951

Review 7. Cystic fibrosis.

Authors: Brian P O'Sullivan; Steven D Freedman
Journal: Lancet Date: 2009-05-04 Impact factor: 79.321

8. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.

Authors: Claudine Guilbault; Juan B De Sanctis; Gabriella Wojewodka; Zienab Saeed; Claude Lachance; Thomas A A Skinner; Regina M Vilela; Stan Kubow; Larry C Lands; Marian Hajduch; Elias Matouk; Danuta Radzioch
Journal: Am J Respir Cell Mol Biol Date: 2007-07-26 Impact factor: 6.914

Review 9. Ceramide in cystic fibrosis.

Authors: Heike Grassmé; Joachim Riethmüller; Erich Gulbins
Journal: Handb Exp Pharmacol Date: 2013